Wells Fargo & Company Tango Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 15,274 shares of TNGX stock, worth $106,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,274
Previous 15,813
3.41%
Holding current value
$106,612
Previous $125,000
4.8%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TNGX
# of Institutions
121Shares Held
89.1MCall Options Held
2.6KPut Options Held
1K-
Trv Gp Iv, LLC Boston, MA19.2MShares$134 Million81.48% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$93 Million4.04% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$57.2 Million3.91% of portfolio
-
Nextech Invest Ag5.53MShares$38.6 Million8.96% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$36.8 Million1.32% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $615M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...